Ischaemic Lesions in Acute Intracerebral Haemorrhage
CHALLENGE-ICH
1 other identifier
observational
120
1 country
1
Brief Summary
The aim of this observational study is to determine how and why inadequate brain blood flow occurs after bleeding in patients with intracerebral haemorrhage (ICH). Treatment for strokes caused by burst blood vessels involves reducing blood pressure (BP) to stop the bleeding. However, this reduction in BP may affect blood flow, causing blockages in blood vessels within the brain. Fast breathing also affects brain blood flow. Therefore, participants will be asked to undergo a simple brain blood flow assessment using transcranial Doppler (TCD) within 48 hours upon admission to hospital. Patients will then have a follow-up TCD assessment at 4-7 days post-ICH onset, in addition to an MRI scan at \>7 days. This research will help to confirm if blockages after bleeding are caused by reduced blood flow within the brain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2024
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2024
CompletedFirst Posted
Study publicly available on registry
May 13, 2024
CompletedStudy Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2029
September 19, 2024
April 1, 2024
4.7 years
May 7, 2024
September 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Cerebral blood velocity measurements within 48 hours of admission to hospital and 4-7 days after onset in intracerebral haemorrhage patients.
Absolute values (cm/s) in cerebral blood velocity measurements in intracerebral haemorrhage patients.
From enrolment to the end of the follow-up (7 days).
Cerebral blood velocity measurements within 48 hours of admission to hospital and 4-7 days after onset in intracerebral haemorrhage patients.
Percentage change (%) in cerebral blood velocity measurements in intracerebral haemorrhage patients.
From enrolment to the end of the follow-up (7 days).
End-tidal carbon dioxide measurements within 48 hours of admission to hospital and 4-7 days after onset in intracerebral haemorrhage patients.
Absolute values (mmHg) in end-tidal carbon dioxide measurements in intracerebral haemorrhage patients.
From enrolment to the end of the follow-up (7 days).
End-tidal carbon dioxide measurements within 48 hours of admission to hospital and 4-7 days after onset in intracerebral haemorrhage patients.
Percentage change (%) in end-tidal carbon dioxide measurements in intracerebral haemorrhage patients.
From enrolment to the end of the follow-up (7 days).
Secondary Outcomes (2)
Arterial spin labelling magnetic resonance imaging measurements >7 days post-intracerebral haemorrhage onset.
From enrolment to the magnetic resonance imaging scan (<7 days post-intracerebral haemorrhage onset).
Arterial spin labelling magnetic resonance imaging measurements >7 days post-intracerebral haemorrhage onset.
From enrolment to the magnetic resonance imaging scan (<7 days post-intracerebral haemorrhage onset).
Study Arms (1)
Intracerebral Haemorrhage Patients
Patients with a clinical diagnosis of haemorrhagic stroke on CT imaging within 48 hours of onset (for patients waking with a stroke, time of onset will be taken to be the time when the patient was last asymptomatic). This is a non-intervention study so no intervention will be given. However, the investigators will observe changes in cerebral haemodynamics of this group within 48 hours of stroke onset and within 3-7 days post-onset.
Interventions
TCD will be used to measure cerebral blood velocity (CBv) in the middle and posterior cerebral arteries (MCA and PCA). Following confirmation of a suitable TCD window, participants will undergo a ten-minute rest period in the supine or semi-supine position. Continuous measurements of CBv, blood pressure (BP), heart rate, and end-tidal carbon dioxide will be recorded. Baseline BP will be measured using an automated BP device prior to each recording to allow calibration of the files offline for analysis. This will occur at the first visit and at follow-up, 4-7 days post-onset of intracerebral haemorrhage.
Eligibility Criteria
The participants will be recruited from the Leicester Royal Infirmary stroke wards.
You may qualify if:
- Clinical diagnosis of a haemorrhagic stroke on CT imaging within 48 hours of onset (for patients waking with a stroke, time of onset will be taken to be the time when the patient was last asymptomatic).
- Male or female, aged 18 years or above.
You may not qualify if:
- MRI imaging is contraindicated or unlikely to tolerate scanning process due to clinical instability (GCS \<8, unable to lie supine).
- Patients requiring anaesthesia.
- Male or Female, aged under 18 years.
- Clinical diagnosis of stroke greater than 48 hours from onset
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Leicesterlead
- University Hospitals, Leicestercollaborator
Study Sites (1)
University Hospitals of Leicester NHS Trust
Leicester, LE1 5WW, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 7, 2024
First Posted
May 13, 2024
Study Start
June 1, 2024
Primary Completion (Estimated)
January 31, 2029
Study Completion (Estimated)
January 31, 2029
Last Updated
September 19, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share
Individual patient data will not be shared, however once analysed and combined (statistically through mean averages etc), the results will be compiled into a report and submitted to a relevant journal, allowing researchers to view them.